The ongoing discovery of disease associated biomarkers is driving the demand for reliable antibodies to facilitate research in the biomedical field. Molecular biomarkers help to accelerate our understanding of the cellular and molecular mechanisms of diseases in terms of initiation, development and progression. In addition, specific biomarkers may have an important role in disease diagnosis, monitoring, prognosis and therapy.  Over the past decade, Everest Biotech has continued to recognise the potential of emerging biomarkers and to develop high quality antigen affinity purified goat polyclonal antibodies for the biomedical research market. Everest Biotech manufactures a vast range of antibodies against different biomarkers and, for a limited period, can offer 37 (see table) of their most sought after antibodies at a promotional price of $NZ340/0.1mg vial (excl) to all Huntingtree customers.

This unique offer includes affinity-purified antibodies to markers like AIF1/IBA1, Arrestin beta 2, FOXP3, FOXL2, NQO1, NUMB, etc. that are attracting significant interest in the various fields of disease.  Everest antibodies are direct to human and rodent proteins and many cross react with a range of different species.  These highly specific antibodies are suitable for use in a wide range of applications including western blotting, ELISA and immunohistology.